Surender Kumar has been advisory board member of Boehringer Ingelheim India, Astra Zeneca, Jansen, Novo Nordisk, Eli Lilly, MSD, Sanofi-Aventis, USV Private Limited, Eris Lifesciences, Lupin Limited, and Roche Diabetes Care India Pvt
Exposure to 9-tetrahydrocannabinol impairs the differentiation of human monocyte-derived dendritic cells and their capacity for T cell activation
GLP-1 therapy is non-invasive isnt that enough for many patients? For some patients, GLP-1 therapy may be appropriate, especially early or in mild obesity
GLP-1s including semaglutides (Ozempic and Wegovy) and tirzepatides (Mounjaro and Zepbound) have "special effects on multi-systems of the body," Decotiis said
doi: 10.3390/epidemiologia5030032 3
If a provider publishes processing timeframes and verification steps up front, that is a positive signal